Ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria

Published:2020-02-14 Issue:3 Volume:20 Page:227-237
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Lee Jong Wook¹,Kulasekararaj Austin G²

Affiliation:

1. Division of Hematology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

2. Department of Haematological Medicine, King’s College Hospital, NHS Foundation Trust and King’s College, London, UK

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2020.1725468

Reference48 articles.

1. Mutations in the PIG-A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frameshift type

2. Paroxysmal nocturnal hemoglobinuria

3. The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin

4. The prothrombotic state in paroxysmal nocturnal hemoglobinuria: a multifaceted source

5. Natural History of Paroxysmal Nocturnal Hemoglobinuria

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics and management of paroxysmal nocturnal haemoglobinuria in Latin America: a narrative review;Annals of Hematology;2024-09-05

2. Exploring treatment strategies for paroxysmal nocturnal hemoglobinuria: an overview of registered clinical trials;Current Medical Research and Opinion;2024-05-16

3. Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria;Hematology;2024-03-21

4. Swiss Survey on current practices and opinions on clinical constellations triggering the search for PNH clones;Frontiers in Medicine;2023-07-26

5. Interim analysis of post-marketing surveillance of ravulizumab for paroxysmal nocturnal hemoglobinuria in Japan;International Journal of Hematology;2023-07-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3